95 full
Release time:
2022-04-06
The recent international situation is complex and volatile, and the global economy has just eased from the epidemic, but with the changes in the conflict situation between Russia and Ukraine, oil prices have been rising. The sharp increase in international and domestic oil prices has brought 95 gasoline into the era of 9 yuan, causing drivers to cry out at the same time. The way to show off one's wealth has also changed from drinking bottled milk tea, having the winter Olympics mascot ice pier and granulated sugar orange freedom to saying "95 full " at the gas station. The
network is full of obstacles poking fun at oil prices, such as "92 full, debt full ", "95 full, ruin ", "98 full, three generations of repayment " vividly poking fun at the sharp increase in travel costs of car owners caused by the sharp rise in oil prices, saddling the bitterness of car owners. It is understood that it costs about 500 yuan to fill up a box of 95 gasoline, one box of oil for a bicycle and four boxes of oil for a battery car. Based on this, car owners have expressed their desire to go to work by bike or simply run directly.
The rise in oil prices can be described as a whole. With the rise of oil prices, the relevant industrial chain is affected, the most direct is that new energy vehicles have once again become the hot target of car owners. Rising oil prices also cause inconvenience to our overall lives. The increase in transportation costs is accompanied by rising prices, and the cost of living increases. Under the condition of unchanged social welfare benefits and wages, people's living standards and consumption levels are reduced, which leads to a decrease in the happiness index of life.
At present, most office workers rely on transportation. They sit in the office for a day. They are seriously lack of exercise. As a result, various elderly diseases such as hypertension, diabetes, hyperlipidemia, and hyperuric acid are becoming younger. Although the rise in oil prices has increased people's cost of living, in a sense, it has prompted people to choose more economical, environmentally friendly, green and healthy travel modes such as public transport, cycling or walking to work, which is conducive to reducing air pollution, reducing energy consumption and improving the utilization rate of transportation resources.
(from Jianmei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31